Topically Applied IDP-118 Lotion and HP Monad Lotion in Subjects With Moderate to Severe Plaque Psoriasis

Completed · Phase 1

Conditions studied: Psoriasis

In brief

Suppression Potential of Topically Applied IDP-118 Lotion and HP Monad Lotion in Subjects with Moderate to Severe Plaque Psoriasis.

Key facts

Study ID

NCT03058744

Run by

Bausch Health Americas, Inc.

People needed

94

Starts

2015-04-01

Expected to finish

2017-01-01

Last updated by the study team

2017-06-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or Female of any race, at least 18 years old of age (inclusive)
• Freely provides both written and oral informed consent.
• Has a clinical diagnosis of psoriasis at the Baseline visit with an Investigator's Global Assessment Score of 3 or 4. The face, scalp ,axillae, and intertriginous areas are to be excluded in this calculation.
• Has an area of plaque psoriasis for topical treatment that involves a BSA of at least 20%.
• The willing and able to avoid prolonged exposure of the treatment area to ultraviolet radiation (natural and artificial) for the duration of the study.
• Key Exclusion Criteria:
• Has spontaneously improving or rapidly deteriorating plaque psoriasis or postural psoriasis, as determined by the investigator.
• Presents with psoriasis that was treated with prescription medication and failed to respond to presents).
• Has a history of adrenal disease.
• Presents with any other concurrent skin conditions that could interfere with the evaluation of the treatment areas, as determined by the investigator.
• Is pregnant, nursing, or planning pregnancy during the study period.

Where it is running

• Valeant Site 12 — Anaheim, California, United States
• Valeant Site 05 — Encino, California, United States
• Valeant Site 01 — San Diego, California, United States
• Valeant Site 07 — Santa Rosa, California, United States
• Valeant Site 10 — Orange Park, Florida, United States
• Valeant Site 09 — Sanford, Florida, United States
• Valeant Site 08 — Atlanta, Georgia, United States
• Valeant Site 04 — Plainfield, Indiana, United States
• Valeant Site 06 — New York, New York, United States
• Valeant Site 11 — Philadelphia, Pennsylvania, United States
• Valeant Site 03 — Austin, Texas, United States
• Valeant Site 02 — Katy, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.